Smoking cessation avatar-led Acceptance and Commitment Therapy digital intervention: feasibility and acceptability in young adults.

Acceptance and Commitment Therapy Avatar Digital intervention Feasibility and Acceptability Smoking Cessation

Journal

Translational behavioral medicine
ISSN: 1613-9860
Titre abrégé: Transl Behav Med
Pays: England
ID NLM: 101554668

Informations de publication

Date de publication:
11 02 2021
Historique:
pubmed: 20 10 2019
medline: 19 8 2021
entrez: 20 10 2019
Statut: ppublish

Résumé

Smoking remains a global concern especially among youth and smoking cessation interventions have not been particularly successful with this age group. The aim of the present study was to evaluate the feasibility and acceptability of an innovative avatar-led, digital intervention grounded in Acceptance and Commitment Therapy (ACT) for smoking cessation in youth. Participants were 49 university student smokers, aged 18-28 years old (Mage = 22.50, SD = 2.56; 64.3% females). Participants found the program satisfactory, useful, and motivating. Participants enjoyed the digitally unique components of the intervention, such as videos, metaphors, and games, more than the overall graphics and the appearance of the avatars. Results of this study are encouraging for the acceptability and satisfaction with avatar-led digitized ACT interventions for smoking cessation targeting young smokers. Participants suggested that future program advances should include a more reality-based user experience and more interactive avatars. Future adaptations should consider additional ways to decrease attrition rates and further increase satisfaction and motivation to complete the program and quit smoking.

Identifiants

pubmed: 31628476
pii: 5599754
doi: 10.1093/tbm/ibz128
pmc: PMC8505109
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

198-205

Informations de copyright

© Society of Behavioral Medicine 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

J Hypertens. 2003 Oct;21(10):1897-903
pubmed: 14508196
Gen Physiol Biophys. 2014;33(3):365-72
pubmed: 24968411
Physiol Rev. 1990 Oct;70(4):1067-116
pubmed: 2217555
Am J Physiol Renal Physiol. 2016 Jul 1;311(1):F195-206
pubmed: 26823279
Am J Physiol Renal Physiol. 2002 Jan;282(1):F19-25
pubmed: 11739108
J Clin Invest. 1994 Jun;93(6):2431-7
pubmed: 8200978
Hypertension. 2014 Aug;64(2):378-83
pubmed: 24842923
Am J Physiol. 1993 Jun;264(6 Pt 2):F989-95
pubmed: 7686719
Am J Physiol. 1992 Jun;262(6 Pt 2):F943-9
pubmed: 1621818
Compr Physiol. 2013 Apr;3(2):957-76
pubmed: 23720336
J Am Soc Nephrol. 1999 Jan;10 Suppl 11:S23-9
pubmed: 9892137
Am J Physiol Cell Physiol. 2010 Oct;299(4):C750-9
pubmed: 20592241
Am J Physiol Renal Physiol. 2014 Jul 15;307(2):F222-33
pubmed: 24740791
PLoS One. 2015 Feb 23;10(2):e0117899
pubmed: 25706121
Anat Histol Embryol. 2006 Apr;35(2):130-8
pubmed: 16542179
Biochem Biophys Res Commun. 2009 Feb 27;380(1):81-6
pubmed: 19161983
Adv Biomed Res. 2018 Jan 30;7:12
pubmed: 29456983
Am J Physiol Renal Physiol. 2015 Jun 1;308(11):F1197-9
pubmed: 25834073
Kidney Int Suppl (2011). 2013 Dec;3(4):321-325
pubmed: 25019012
J Hypertens Suppl. 1988 Dec;6(4):S442-5
pubmed: 3241234
Pharmacol Rev. 2007 Sep;59(3):251-87
pubmed: 17878513
Hypertension. 2011 Apr;57(4):859-64
pubmed: 21321306
Physiol Rev. 2010 Apr;90(2):607-73
pubmed: 20393195
FASEB J. 2012 May;26(5):1821-30
pubmed: 22302831
Am J Physiol. 1999 Sep;277(3):F437-46
pubmed: 10484527
Am J Physiol Renal Physiol. 2010 Nov;299(5):F983-90
pubmed: 20810609
J Surg Res. 1995 Jul;59(1):135-40
pubmed: 7630117
Hypertension. 2002 Mar 1;39(3):799-802
pubmed: 11897767
Am J Physiol Renal Physiol. 2008 Aug;295(2):F515-24
pubmed: 18495795
Am J Hypertens. 2012 Jun;25(6):684-9
pubmed: 22378037
J Am Soc Nephrol. 2000 May;11(5):847-855
pubmed: 10770962
J Am Soc Hypertens. 2009 Mar-Apr;3(2):96-104
pubmed: 20046983
Pflugers Arch. 2002 Jul;444(4):499-505
pubmed: 12136269
Am J Physiol Renal Physiol. 2016 May 1;310(10):F1103-12
pubmed: 26864937
Am J Physiol Heart Circ Physiol. 2005 May;288(5):H2289-97
pubmed: 15615839
Cytokine. 2010 Apr;50(1):1-14
pubmed: 20036577
J Mol Med (Berl). 2017 May;95(5):473-486
pubmed: 28160049
Ther Adv Cardiovasc Dis. 2015 Aug;9(4):181-90
pubmed: 25987608
Graefes Arch Clin Exp Ophthalmol. 2015 Jul;253(7):1053-9
pubmed: 25677099
Hypertension. 2008 Jun;51(6):1590-6
pubmed: 18426992
Peptides. 2015 Sep;71:250-8
pubmed: 26256416
Clin Sci (Lond). 2010 Jul 23;119(9):385-94
pubmed: 20528771
N Am J Med Sci (Boston). 2011 Oct 1;4(4):183-190
pubmed: 22389749
Am J Physiol Renal Physiol. 2014 Oct 15;307(8):F949-61
pubmed: 25164083
Ochsner J. 2013 Spring;13(1):26-32
pubmed: 23532382
Hypertension. 1999 Jan;33(1 Pt 2):340-6
pubmed: 9931127
Clin Exp Hypertens. 2016;38(1):56-62
pubmed: 26268856
Electrolyte Blood Press. 2008 Jun;6(1):42-50
pubmed: 24459521
Hypertension. 2011 Feb;57(2):308-13
pubmed: 21189405
Hypertension. 1997 Oct;30(4):859-67
pubmed: 9336385
Am J Hypertens. 2008 Dec;21(12):1359-61
pubmed: 18802431
Am J Physiol Renal Physiol. 2016 Aug 1;311(2):F278-90
pubmed: 27194718
Am J Physiol Renal Physiol. 2005 Feb;288(2):F420-7
pubmed: 15467006
Hypertension. 1992 Dec;20(6):763-7
pubmed: 1333445
Mol Cell Endocrinol. 2009 Nov 13;311(1-2):24-31
pubmed: 19583994
Curr Hypertens Rep. 2003 Apr;5(2):135-43
pubmed: 12642013
J Hypertens. 2002 Aug;20(8):1615-24
pubmed: 12172324
J Biol Chem. 2002 May 17;277(20):17962-9
pubmed: 11830581
Am J Physiol Renal Physiol. 2005 Sep;289(3):F632-7
pubmed: 15870381
Int J Hypertens. 2011;2011:132405
pubmed: 21747971
Br J Pharmacol. 1999 Aug;127(8):1929-35
pubmed: 10482926
Am J Pathol. 2002 Nov;161(5):1679-93
pubmed: 12414515
Am J Physiol Renal Physiol. 2016 May 15;310(10):F1000-7
pubmed: 27009340
Hypertension. 2012 Jan;59(1):136-44
pubmed: 22068875
Hypertension. 2004 Aug;44(2):223-9
pubmed: 15226276
Hypertension. 2009 Dec;54(6):1269-77
pubmed: 19858406
J Am Soc Nephrol. 1997 Nov;8(11):1658-67
pubmed: 9355068
Hypertension. 2017 Oct;70(4):831-838
pubmed: 28827476
Cell Physiol Biochem. 2009;23(4-6):265-76
pubmed: 19471094
Hypertension. 1999 May;33(5):1237-42
pubmed: 10334818
Hypertension. 2004 May;43(5):1126-32
pubmed: 15037565
Am J Physiol. 1997 Jul;273(1 Pt 2):F170-7
pubmed: 9249605
Br J Pharmacol. 2013 Jun;169(3):477-92
pubmed: 23488800
Hypertension. 2008 Jun;51(6):1597-604
pubmed: 18413493
Exp Biol Med (Maywood). 2014 Jun;239(6):758-69
pubmed: 24719376
Hypertension. 2002 Feb;39(2 Pt 2):316-22
pubmed: 11882566
Kidney Int. 2009 Jan;75(2):156-66
pubmed: 18923387
Curr Hypertens Rep. 2008 Jun;10(3):188-93
pubmed: 18765088
Arterioscler Thromb Vasc Biol. 2016 Feb;36(2):256-65
pubmed: 26681751
Cardiovasc Res. 2004 Jun 1;62(3):587-93
pubmed: 15158151
Curr Hypertens Rep. 2017 Mar;19(3):21
pubmed: 28271418
Hypertension. 1999 Jan;33(1 Pt 2):366-72
pubmed: 9931131
Acta Physiol Scand. 1993 Jun;148(2):137-42
pubmed: 8352025
J Hypertens. 1986 Feb;4(1):65-9
pubmed: 3514748
Curr Opin Pharmacol. 2015 Apr;21:14-9
pubmed: 25523165
Hypertension. 1997 Nov;30(5):1238-46
pubmed: 9369282
Am J Physiol Renal Physiol. 2019 Sep 1;317(3):F670-F682
pubmed: 31339773
Hypertension. 1999 Dec;34(6):1265-74
pubmed: 10601129
J Exp Med. 2007 Oct 1;204(10):2449-60
pubmed: 17875676
Stroke. 2006 May;37(5):1271-6
pubmed: 16601219
Nephrol Dial Transplant. 2003 Jun;18(6):1042-5
pubmed: 12748331
Hypertension. 1999 Jan;33(1 Pt 2):347-53
pubmed: 9931128
Int J Clin Med. 2011 Sep 1;2(1):378-387
pubmed: 22247811
Curr Opin Nephrol Hypertens. 2013 Jan;22(1):32-6
pubmed: 23010762
Gend Med. 2012 Aug;9(4):207-18
pubmed: 22795463
J Renin Angiotensin Aldosterone Syst. 2011 Dec;12(4):413-9
pubmed: 21436210
Hypertension. 1997 Sep;30(3 Pt 1):337-44
pubmed: 9314414
Expert Opin Investig Drugs. 2006 Oct;15(10):1137-9
pubmed: 16989590
Am J Physiol Renal Physiol. 2013 May 15;304(10):F1231-42
pubmed: 23515717
Kidney Int Suppl (2011). 2013 Dec;3(4):368-371
pubmed: 25019021
Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3521-5
pubmed: 7724593
J Clin Invest. 1997 Mar 1;99(5):1072-81
pubmed: 9062366
J Am Soc Nephrol. 2012 Jul;23(7):1181-9
pubmed: 22518004
Am J Physiol Heart Circ Physiol. 2006 Mar;290(3):H935-40
pubmed: 16284237
Am J Pathol. 2016 Nov;186(11):2846-2856
pubmed: 27640148
Am J Physiol Renal Physiol. 2007 Jan;292(1):F330-9
pubmed: 16804106
Am J Physiol Renal Physiol. 2008 Sep;295(3):F772-9
pubmed: 18579707
Pflugers Arch. 2013 Jan;465(1):121-32
pubmed: 22990760
Nat Rev Dis Primers. 2018 Mar 22;4:18014
pubmed: 29565029
Hypertension. 2009 Feb;53(2):344-50
pubmed: 19075095
Trends Cardiovasc Med. 2016 Apr;26(3):221-8
pubmed: 26169314
Am J Physiol Renal Physiol. 2008 Jul;295(1):F283-9
pubmed: 18463317
Hypertension. 2012 Feb;59(2):409-14
pubmed: 22158645
J Cardiovasc Pharmacol. 2015 Mar;65(3):226-32
pubmed: 25636068
Mayo Clin Proc. 2011 Jul;86(7):649-57
pubmed: 21719621
Circ Res. 2014 Jul 18;115(3):388-99
pubmed: 24903104
Hypertension. 1999 Jan;33(1):96-101
pubmed: 9931088
Hypertension. 2011 Feb;57(2):275-82
pubmed: 21189402
Exp Ther Med. 2017 Jun;13(6):3291-3296
pubmed: 28587402
Am J Physiol Renal Physiol. 2011 Mar;300(3):F749-55
pubmed: 21209009
Am J Physiol Renal Physiol. 2008 Dec;295(6):F1836-44
pubmed: 18922887
Sci Rep. 2017 Apr 05;7:45473
pubmed: 28378780
Am Fam Physician. 2017 Oct 1;96(7):453-461
pubmed: 29094913
Proc Natl Acad Sci U S A. 2006 Nov 21;103(47):17985-90
pubmed: 17090678
Am J Physiol Renal Physiol. 2010 Jan;298(1):F150-7
pubmed: 19846570

Auteurs

Maria Karekla (M)

Department of Psychology, University of Cyprus, Nicosia, Cyprus.

Stella Nicoleta Savvides (SN)

Department of Psychology, University of Cyprus, Nicosia, Cyprus.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH